Table: Aska Pharmaceutical -Q1 group results

ASKA Pharmaceutical Holdings

04/08/2016 07:00

Aug 4 (Reuters)-  
             Aska Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             11.99               10.72            45.00     
                 (+11.8 pct)         (+2.8 pct)       (+4.1 pct)   
  Operating        462 mln             233 mln            1.00     
                 (+98.5 pct)         (-32.7 pct)      (-14.3 pct)  
  Recurring        594 mln             366 mln            1.20     
                 (+62.1 pct)         (-11.4 pct)      (-21.2 pct)  
  Net              526 mln             187 mln            1.00     
                (+181.1 pct)         (-36.7 pct)      (+42.6 pct)  
  EPS             18.84 yen           6.72 yen         35.81 yen   
  Ann Div                             14.00 yen        14.00 yen   
  -Q2 div                             7.00 yen         7.00 yen    
  -Q4 div                             7.00 yen         7.00 yen    
   
  NOTE - Aska Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T  
  ((Tokyo Headline News Desk +813 6441 1812))